Sarissa Capital Management LP Amarin Corp Plcuk Transaction History
Sarissa Capital Management LP
- $366 Million
- Q1 2025
A detailed history of Sarissa Capital Management LP transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Sarissa Capital Management LP holds 24,850,623 shares of AMRN stock, worth $386 Million. This represents 60.8% of its overall portfolio holdings.
Number of Shares
24,850,623
Previous 24,850,623
-0.0%
Holding current value
$386 Million
Previous $11.9 Million
1766.71%
% of portfolio
60.8%
Previous 3.7%
Shares
8 transactions
Others Institutions Holding AMRN
# of Institutions
141Shares Held
69MCall Options Held
133KPut Options Held
26.4K-
Kynam Capital Management, LP Princeton, NJ12.4MShares$193 Million9.37% of portfolio
-
Acadian Asset Management LLC Boston, MA3.79MShares$59 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY3.4MShares$52.9 Million3.37% of portfolio
-
Morgan Stanley New York, NY2.62MShares$40.8 Million0.0% of portfolio
-
Waterfront Wealth Inc.2.51MShares$39.1 Million5.52% of portfolio
About AMARIN CORP PLCUK
- Ticker AMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 403,206,016
- Market Cap $6.27B
- Description
- Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...